做好专科医院申报国家药物临床试验机构资格认定工作

刘真,代荫梅,李坚

中国药学杂志 ›› 2013, Vol. 48 ›› Issue (18) : 1602-1603.

PDF(425 KB)
PDF(425 KB)
中国药学杂志 ›› 2013, Vol. 48 ›› Issue (18) : 1602-1603. DOI: 10.11669/cpj.2013.18.023
药事管理

做好专科医院申报国家药物临床试验机构资格认定工作

  • 刘真,代荫梅,李坚
作者信息 +

Practice and Approach of Applying for Accreditation of National Drug Clinical Trial Institution by Specialized Hospitals

  • LIU Zhen, DAI Yin-mei, LI Jian
Author information +
文章历史 +

摘要

目的为专科医院申报国家药物临床试验机构提供借鉴。方法参阅国家关于药物临床试验机构资格认定的相关规定,结合专科医院的特点、阐述专科医院在申请资格认定过程中的实际操作和体会。结果与结论专科医院申报国家药物临床试验机构需明了自身劣势,挖掘临床优势资源、强化优势专业、合理利用外部资源以弥补自身不足。

Abstract

OBJECTIVE To provide some references for speciaslized hospital to apply for national drug clinical trial institution. METHODS According to the state on related clinical test qualification of the relevant provisions, combined with the characteristics of specialist hospitals, we described in the application process of qualification and experience of the actual operation. RESULTS AND CONCLUSION Specialized hospital should understand our own weaknesses, mining clinical advantages of resources, strengthen professional advantages, with rational use of external resources in order to make up for our lack.

关键词

药物临床试验 / 资格认证 / 专科医院

Key words

drug clinical trial / qualification / special hospital

引用本文

导出引用
刘真,代荫梅,李坚. 做好专科医院申报国家药物临床试验机构资格认定工作[J]. 中国药学杂志, 2013, 48(18): 1602-1603 https://doi.org/10.11669/cpj.2013.18.023
LIU Zhen, DAI Yin-mei, LI Jian. Practice and Approach of Applying for Accreditation of National Drug Clinical Trial Institution by Specialized Hospitals[J]. Chinese Pharmaceutical Journal, 2013, 48(18): 1602-1603 https://doi.org/10.11669/cpj.2013.18.023
中图分类号: R95   

参考文献

[1] XIE Q. Brief description of the current organizational construction of drug clinical trial institutes in China. Chin J Clin Pharmacol(中国临床药理学杂志),2007,23(5):397-400. [2] Focal problems of drug clinical trial in China . China Prescription Drug(中国处方药),2009,4(85):35-38. [3] YU S H. Practice and approach of special hospital on developing. Chin Hosp Manage(中国医院管理), 2007,27(1):52-53. [4] BAI C Z,WANG C,ZHAO Z G,et al. Strengthen recgnition of ethical review committees and improve the reviewing quality. Chin Pharm J(中国药学杂志),2011,46(22):1771-1772. [5] LIU S L, WANG X Q,XIONG N N, et al. Ethic review in clinical research: Women and pregnant women . Chin J Clin Pharmacol Therapeut(中国临床药理学与治疗学),2006,11(4):477-480. [6] HONG M H. Preliminary exploration on the building of clinical trial institutions. China Prescription Drug(中国处方药),2010,6(99):10-11. [7] QUAN J X, ZHAO M, SHAN A L. Function and existing some problem of contract research organization in clinical trial. Chin J Clin Pharmacol(中国临床药理学杂志),26(7):549-551. [8] Good Clinical Practice. SFDA. . http://www. sda. gov. cn/WS01/CL0053/24473. html. [9] On the issuance of the notice of the clinical trials of drugs accreditation odies (Trial). . SFDA. . http://www. sda. gov. cn/WS01/CL0058/9346. html. Drug Registration. SFDA. . http://www. sda. gov. cn/WS01/CL0053/24529_1. html. Declaration of Helsinki(V2008) . The 59th WMA. . http://baike. baidu. com/view/1031580. html. QIU R Z. International organizations of medical sciences(CIOMS) international ethical guidelines for biomedical research involving human subjects. Chin Med Ethics(中国医学伦理学),2002,16(4):20-21. Harmonized Tripartite for Guideline for GCP. 1997, ICH. E6.. http://wenku. Baidu. com/view/386445c69ec3d5bbfd0a7467 html.
PDF(425 KB)

Accesses

Citation

Detail

段落导航
相关文章

/